Identifying the Resistant Bacterial Pattern in Patients with Diabetic Foot Ulcer
DOI:
https://doi.org/10.55544/jrasb.1.4.20Keywords:
Diabetes, foot ulcer, resistant bacteriaAbstract
Background: Diabetes is a term used to describe a group of metabolic disorders that are hyperglycemic due to deficiencies in insulin secretion, insulin action, or both. Diabetes complications are common in both type 1 and type 2 diabetes patients, and they are responsible for significant morbidity and mortality. One of the persistent diabetes complications is a foot ulcer associated with neuropathy. These ulcers eventually lead to infections in the diabetic foot. Diabetic foot diseases such as ulceration, gangrene, Charcot joint, and fracture are common causes of amputation.
Methodology: The study was conducted of 23 samples from foot ulcers diabetic disease. Relevant clinical, biochemical, and microbiological sensitivity evaluations were carried out on the subjects.
Results: This study has shown that the highest ratio of isolated bacteria from diabetic foot ulcer patients were Staphylococcus aureus, Pseudomonas aeruginosa and Streptococcus pyogenes respectively. The isolated Gram-positive bacteria were more than isolated gram-negative bacteria. Both Streptococcus pyogenes and Staphylococcus aureus showed a high resistance to Benzylpenicillin and Oxacillin, Whereas some isolates of Pseudomonas aeruginosa showed resistance to Imipenem, meropenem and Piperacillin/Tazobactam. Escherichia coli were resistant to Ticarcillin, Aztreonam, Cefepime and Ceftazidime. Klebsiella pneumoniae show high resistant to all of antibiotics. Proteus mirabilis resist to Aztreonam, Cefepime, Ceftazidime, Gentamicin, meropenem, Piperacillin/ Tazobactam, Trimethoprim/ Sulfamethoxazole and Tobramycin.
Conclusion: The outcome of current study has shown that the isolated Gram-positive bacteria were more than isolated gram-negative bacteria in foot ulcer patients, with different pattern of resistance to the studied antibiotics.
Downloads
Metrics
References
Holt RI, Cockram C, Flyvbjerg A, Goldstein BJ, editors. Textbook of diabetes. John Wiley & Sons; 2017 Mar 6.
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. Diabetes care. 2018 Jan 1;41(Supplement 1): S13-27.
American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes care. 2015 Jan 1;38(Supplement 1): S8-16.
Razzak RA, Hussein W. Postural visual dependence in asymptomatic type 2 diabetic patients without peripheral neuropathy during a postural challenging task. Journal of Diabetes and its Complications. 2016 Apr 1;30(3):501-6.
Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Physical therapy. 2008 Nov 1;88(11):1254-64.
Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M. Complications of diabetes 2017.
Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes care. 2017 Jan 1;40(1):136-54.
Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 1994;130:489–93.
Shaw JE, Boulton AJ. The pathogenesis of diabetic foot problems: an overview. Diabetes 1997;46(Suppl. 2):S58–61.
Boulton A. Late sequelae of diabetic neuropathy. In: Boulton A, editor. Diabetic neuropathy. Lancaster: Marius Press; 1997. p. 63–76.
Lindberger M, Schroder HD, Schultzberg M, et al. Nerve fibre studies in skin biopsies in peripheral neuropathies. I. Immunohistochemical analysis of neuropeptides in diabetes mellitus. J Neurol Sci.989;93:289–96.
Galkowska H, Olszewski WL, Wojewodzka U, Rosinski G, Karnafel W. Neurogenic factors in the impaired healing of diabetic foot ulcers. J Surg Res 2006;134:252–8.
Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005;366:1736–43.
Gulam-Abbas Z, Lutale JK, Morbach S, Archibald LK. Clinical outcome of diabetes patients hospitalized with foot ulcers, Dar es Salaam, Tanzania. Diabet Med. 2002;19:575-9.
Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382-7.
Rooh-Ul-Muqim, Ahmed M, Griffin S. Evaluation and management of diabetic foot according to Wagner’s classification. A study of 100 cases. J Ayub Med Coll Abbottabad. 2003;15:39-42.
Eneroth M, Apelqvist J, Stenstrom A. Clinical characteristics and outcome in 223 diabetic patients with deep foot infections. Foot Ankle Int. 1997;18:716-22.
Candel Gonzalez FJ, Alramadan M, Matesanz M, Diaz A, Gonzalez-Romo F, Candel I, et al. Infections in diabetic foot ulcers. Eur J Intern Med. 2003;14:341-3.
Chincholikar DA, Pal RB. Study of fungal and bacterial infections of the diabetic foot. Indian J Pathol Microbiol. 2002; 45:15-22.
Lazzarini, Peter A., Ryan T. Crews, Jaap J. van Netten, Sicco A. Bus, Malindu E. Fernando, Paul J. Chadwick, and Bijan Najafi. "Measuring plantar tissue stress in people with diabetic peripheral neuropathy: a critical concept in diabetic foot management." Journal of diabetes science and technology 13, no. 5 (2019): 869-880.
Greenwood, D.; Slack, R. C. B.; Peutherer, J. F. and Barer, M. R. (2007). Medical Microbiology. A Guide to microbial Infections: Pathogenesis, Immunity, Laboratory Diagnosis and Control. 6thed. Churchill Livingstone.
Collee, J. S. ; Fraser, A. G. ; Marmion, B.P. and simmons, A. (1996) . Mackie & Mecarthey Paractical medical microbiology . 20th ed. Vol.1. Churchill living stone . London.
Bergey, D.H.and John, G.H. (1994). Bergey’s manual of deter-minative biology, William and Wilkins, 9th ed., Chapter4, Pp. 181-186
Brooks GF. Jawetz, Melnick, & Adelberg's medical microbiology/Geo. F. Brooks. New York; Chicago: McGraw Hill Medical,; 2010.
Bauer, A. W.; Kirby, W. M. M.; Sherris, J. C. and Truck, M. (1966). Antibiotic susceptibility testing by a standardized single disk method. Am. Journal Clin. Pathol., 43, pp. 493-496.
Clinical and Laboratory Standards Institute (CLSI) .(2014). Performance standards for antimicrobial susceptibility testing, 24th informational supplement, Vol. 34 No. 1 , Pennsylvania USA.
Released SI. SPSS for windows, version 16.0. SPSS Inc., Chicago. 2007.
Rivera-Tapia,J.A.(2003). Antibiotic resistance, public health problem. Anales Medical Hospital ABC.48(1) , pp. 42-47.
Pollack,R.A., Findlay,L, Mondschein, W. and Modesto, R.(2012). Laboratory Exercises in Microbiology (4th edition).John Wiley & Sons,Inc.,printed in the USA, p. 273.
Noor S, Zubair M, Ahmad J. Diabetic foot ulcer—a review on pathophysiology, classification and microbial etiology. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2015 Jul 1;9(3):192-9.
Mantey I, Hill RL, Foster AV, Wilson S, Wade JJ, Edmonds ME. Infection of foot ulcers with Staphylococcus aureus associated with increased mortality in diabetic patients. Communicable disease and public health. 2000 Dec 1;3:288-90.
Dang CN, Prasad YD, Boulton AJ, Jude EB. Methicillin‐resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabetic Medicine. 2003 Feb;20(2):159-61.
Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes care. 2006 Aug 1;29(8):1727-32.
Shankar EM, Mohan V, Premalatha G, Srinivasan RS, Usha AR. Bacterial etiology of diabetic foot infections in South India. European journal of internal medicine. 2005 Dec 1;16(8):567-70.
Raja NS. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases. Journal of microbiology immunology and infection. 2007 Feb 1;40(1):39.
Lipsky BA, Pecoraro RE, Wheat LJ. The diabetic foot. Soft tissue and bone infection. Infectious disease clinics of North America. 1990 Sep 1;4(3):409-32.
Dang CN, Prasad YD, Boulton AJ, Jude EB. Methicillin‐resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabetic Medicine. 2003 Feb;20(2):159-61.
Ghotaslou R, Memar MY, Alizadeh N. Classification, microbiology and treatment of diabetic foot infections. Journal of wound care. 2018 Jul 2;27(7):434-41.
Younes NA, Bakri FG. Diabetic foot infection. Saudi medical journal. 2006 May 1;27(5):596.
Akhi MT, Ghotaslou R, Asgharzadeh M, Varshochi M, Pirzadeh T, Memar MY, Bialvaei AZ, Sofla HS, Alizadeh N. Bacterial etiology and antibiotic susceptibility pattern of diabetic foot infections in Tabriz, Iran. GMS hygiene and infection control. 2015;10.
Ramakant P, Verma AK, Misra R, Prasad KN, Chand G, Mishra A, Agarwal G, Agarwal A, Mishra SK. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose?. Diabetologia. 2011 Jan;54(1):58-64.
Bansal E, Garg A, Bhatia S, Attri AK, Chander J. Spectrum of microbial flora in diabetic foot ulcers. Indian journal of pathology and microbiology. 2008 Apr 1;51(2):204.
Umadevi S, Kumar S, Joseph NM, Easow JM, Kandhakumari G, Srirangaraj S, Raj S, Stephen S. Microbiological study of diabetic foot infections. Indian journal of medical specialities. 2011 Jan 1;2(1).
Alhubail A, Sewify M, Messenger G, Masoetsa R, Hussain I, Nair S, Tiss A. Microbiological profile of diabetic foot ulcers in Kuwait. Plos one. 2020 Dec 30;15(12):e0244306.
Xie X, Bao Y, Ni L, Liu D, Niu S, Lin H, Li H, Duan C, Yan L, Huang S, Luo Z. Bacterial profile and antibiotic resistance in patients with diabetic foot ulcer in Guangzhou, Southern China: focus on the differences among different Wagner’s grades, IDSA/IWGDF grades, and ulcer types. International journal of endocrinology. 2017 Oct;2017.
Jacoby, G. A. and Munoz-Price, L. S. (2005).“The new beta-lactamases. The New England Journal of medicine, 352(4): 380–391.
Fuda, C.; Suvorov, M.; Vakulenko, S. B. and Mobashery, S. (2004). The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. Journal Biol. Chem. 279, pp. 40802–40806.
Levinson, W. ( 2014 ) . Review of medical microbiology and Immunology .McGraw – Hill. New York .13th ed, P.8.
Nester, E.W., Anderson, D.G., Roberts, C.E., Pearsall, N.N. and Nestor, M.T. (2001). Microbiology a human perspective, 3rd ed. McGraw-Hill Higher Education, pp. 295-512 .
Poole, K. (2004). Resistance to beta-lactam antibiotics, Cell Mol Life Sci, 61(17), pp. 2200–2223.
Al-Gerir, A.Z.(2012). Detection of extended spectrum beta- lactamases and antibiogram profile of Klebsiella species. Ann. Coll. Med. Mosul ; 38 (1), pp. 33-39.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Sura Qusay Ali, Yasir Majid Kamil
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.